ArticleOncogene2018
Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Naoki Shinno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it